Metabolism and epigenetics: drivers of tumor cell plasticity and treatment outcomes

Trends Cancer. 2024 Nov;10(11):992-1008. doi: 10.1016/j.trecan.2024.08.005. Epub 2024 Sep 14.

Abstract

Emerging evidence indicates that metabolism not only is a source of energy and biomaterials for cell division but also acts as a driver of cancer cell plasticity and treatment resistance. This is because metabolic changes lead to remodeling of chromatin and reprogramming of gene expression patterns, furthering tumor cell phenotypic transitions. Therefore, the crosstalk between metabolism and epigenetics seems to hold immense potential for the discovery of novel therapeutic targets for various aggressive tumors. Here, we highlight recent discoveries supporting the concept that the cooperation between metabolism and epigenetics enables cancer to overcome mounting treatment-induced pressures. We discuss how specific metabolites contribute to cancer cell resilience and provide perspective on how simultaneously targeting these key forces could produce synergistic therapeutic effects to improve treatment outcomes.

Keywords: cancer metabolism; epigenetics; histones; metabolites; novel therapeutics; post-translational modifications.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Plasticity* / genetics
  • Drug Resistance, Neoplasm / genetics
  • Energy Metabolism
  • Epigenesis, Genetic*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Neoplasms* / genetics
  • Neoplasms* / metabolism
  • Neoplasms* / pathology
  • Neoplasms* / therapy
  • Treatment Outcome